As per Future Market Insights’ latest industry analysis, the valuation for the global Celiac Disease Diagnostics Market size estimates for 2023 is around US$ 292.8 Million and is projected to exhibit a CAGR growth of close to 8.3% over the forecast period, with an estimated valuation of US$ 647.3 Million by 2033.
A digestive disease known as celiac disease is brought on by eating gluten, a protein present in wheat, barley, and rye. The techniques and procedures used to identify celiac disease, an autoimmune illness brought on by the ingestion of gluten, are referred to as Celiac Disease Diagnostics. These methods of diagnosis seek to establish the presence of celiac disease and validate the diagnosis.
Get Sample Report + Related Graphs & Charts@ https://www.futuremarketinsights.com/reports/sample/rep-gb-17187
The prevalence of celiac disease is increasing worldwide, which is driving the demand for effective treatment options.
There is more study and development being done in this field as celiac disease cases rise. For instance, according to Beyond Celiac, during the past three decades in the industrialized Western world, the rate of new celiac disease diagnosis increased by 7.5% annually. With the increase in demand, research activities in this field are accelerating rapidly.
For instance, on April 4, 2022, Anokion and the Celiac Disease Foundation collaborated on the KAN-101 Phase 1b/2 Study. A medicine being tested called KAN-101 aims to re-establish the liver’s normal immunological tolerance to gluten by specifically targeting those receptors.
Also, as per a study by the University of Medicine and Pharmacy, Bucharest, Romania, and others, computer-aided diagnoses such as image processing techniques and AI techniques DL methods such as convolutional neural network (CNN) have emerged as breakthrough research. Thus, such advancements in technology are a current trend in the market for Celiac Disease Diagnostics.
Overall, these factors are contributing to the growth of the Celiac Disease Diagnostics market, and are expected to continue to drive demand for effective and innovative diagnostics options in the coming years.
Last few days to get reports at discounted prices, offer expires soon!
Request Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-17187
Key Takeaways from Market Study
- Serology Rapid Testing Kits is the leading product segment, and held about 72.4% market share in 2022, due to the increasing demand and adoption of serology rapid testing kits for celiac disease and other conditions indicating the importance of accessible and efficient diagnostic tools.
- ELISA (enzyme-linked immunosorbent assay) is the leading segment in technique, and held about 56.7% market share in 2022, due to its high sensitivity, specificity and for creating antibody panels that include various celiac-specific antibodies.
- By Sample, the blood serum dominated the global Celiac Disease Diagnostics market holding the total market share of about 74.1% by the end of 2022, owing to the monitoring of disease progression and evaluating treatment response in individuals with celiac disease.
- By end user, the diagnostic laboratories dominated the global Celiac Disease Diagnostics market holding a total market share of about 44.0% by the end of 2022, owing to the increasing genetic testing in diagnostic laboratories and increasing research and development efforts.
- By region, North America is leading in the global Celiac Disease Diagnostics market and is expected to continue to do so with a projected CAGR rate of 7.4 % during the forecasted years, due to the increasing prevalence of celiac disease in the region.
“Increasing adoption of diagnostics techniques and growing awareness and diagnosis of the condition to create the lucrative potential for the Celiac Disease Diagnostics market to grow,” says an analyst of Future Market Insights.
Market Competition
Key players in the Celiac Disease Diagnostics market expand their businesses through acquisitions, partnerships, and agreements. The focus of major players is on tactics like increasing sales and applying new technologies for the development of novel products.
- On May 27, 2020, Thermo Fisher entered a strategic partnership with CSL, a global biotech company, for the expansion of its biologics drug substance manufacturing capacity to serve the rapidly growing market.
- In April 2018, two organizations from the Harvard Medical School Celiac Research Program conducted the research in collaboration with the company Glutenostics.
- In October 2021, The Company NanoRepro AG and Viromed Medical GmbH signed an exclusive distribution agreement with an Austrian partner.
Key Players:
- Thermo Fisher Scientific Inc.
- PRIMA Lab SA
- Glutenostics, Inc.
- NanoRepro AG.
- Targeted Genomics
- YORKTEST Laboratories
- Biohit Oyj
- Others
We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-17187
What Does the Report Cover?
Future Market Insights offers a unique perspective and actionable insights on the Celiac Disease Diagnostics market in its latest study, presenting a historical demand assessment of 2012 to 2022 and projections for 2023 to 2033. The global Celiac Disease Diagnostics market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Key Segments Covered in Celiac Disease Diagnostics Industry Research
By Product Type:
- Serology Rapid Testing Kits
- Transglutaminase Antibody Test Kits
- Endomysial Antibody Test Kits
- Anti-Giladin Antibody Test Kits
- Genetic Rapid Testing Kits
By Technique:
- Immunochromatography (Lateral Flow)
- enzyme-linked immunosorbent assay (ELISA)
By Sample:
- Blood Serum
- Body Fluids
By End User:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
- Home Care Setting
About Future Market Insights, Inc.
Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
